{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T23:22:31Z","timestamp":1772839351819,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006680","name":"Takeda Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006680","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","award":["2022\u78144-47"],"award-info":[{"award-number":["2022\u78144-47"]}],"id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K08612"],"award-info":[{"award-number":["JP20K08612"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K07690"],"award-info":[{"award-number":["JP23K07690"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K10956"],"award-info":[{"award-number":["JP24K10956"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Miyagi Kidney Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10157-025-02652-5","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T16:51:44Z","timestamp":1742316704000},"page":"888-898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Construction of arginine vasopressin receptor 2-deficient rats by the rGONAD method"],"prefix":"10.1007","volume":"29","author":[{"given":"Ayaka","family":"Kamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8761-3779","authenticated-orcid":false,"given":"Takuo","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigemitsu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chika","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahito","family":"Kaburaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akari","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Oba-Yabana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takefumi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"2652_CR1","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1681\/ASN.V1161044","volume":"11","author":"M-F Arthus","year":"2000","unstructured":"Arthus M-F, et al. Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol. 2000;11:1044\u201354.","journal-title":"J Am Soc Nephrol"},{"key":"2652_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10157-018-1544-8","volume":"22","author":"F Ando","year":"2018","unstructured":"Ando F, Uchida S. Activation of AQP2 water channels without vasopressin: therapeutic strategies for congenital nephrogenic diabetes insipidus. Clin Exp Nephrol. 2018;22:501\u20137.","journal-title":"Clin Exp Nephrol"},{"key":"2652_CR3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nrneph.2015.89","volume":"11","author":"D Bockenhauer","year":"2015","unstructured":"Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol. 2015;11:576\u201388.","journal-title":"Nat Rev Nephrol"},{"key":"2652_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2012-1044","volume":"34","author":"HB Moeller","year":"2013","unstructured":"Moeller HB, et al. Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. Endocr Rev. 2013;34:278\u2013301.","journal-title":"Endocr Rev"},{"key":"2652_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/BF02549772","volume":"22","author":"T Nakada","year":"1990","unstructured":"Nakada T, et al. Nonobstructive urinary tract dilatation in nephrogenic diabetes insipidus. Int Urol Nephrol. 1990;22:419\u201327.","journal-title":"Int Urol Nephrol"},{"key":"2652_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1877-1173(09)89002-9","volume":"89","author":"DG Bichet","year":"2009","unstructured":"Bichet DG. V2R mutations and nephrogenic diabetes insipidus. Prog Mol Biol Transl Sci. 2009;89:15\u201329.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2652_CR7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1146\/annurev.physiol.63.1.607","volume":"63","author":"JP Morello","year":"2001","unstructured":"Morello JP, Bichet DG. Nephrogenic diabetes insipidus. Annu Rev Physiol. 2001;63:607\u201330.","journal-title":"Annu Rev Physiol"},{"key":"2652_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/ng1092-103","volume":"2","author":"Y Pan","year":"1992","unstructured":"Pan Y, et al. Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nat Genet. 1992;2:103\u20136.","journal-title":"Nat Genet"},{"key":"2652_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/357333a0","volume":"357","author":"M Birnbaumer","year":"1992","unstructured":"Birnbaumer M, et al. Molecular cloning of the receptor for human antidiuretic hormone. Nature. 1992;357:333\u20135.","journal-title":"Nature"},{"key":"2652_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/jcp.21552","volume":"217","author":"E Spanakis","year":"2008","unstructured":"Spanakis E, et al. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol. 2008;217:605\u201317.","journal-title":"J Cell Physiol"},{"key":"2652_CR11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1681\/ASN.2006030240","volume":"17","author":"RW Schrier","year":"2006","unstructured":"Schrier RW. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol. 2006;17:820\u20132.","journal-title":"J Am Soc Nephrol"},{"key":"2652_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2157-7412.1000225","volume":"5","author":"G Procino","year":"2014","unstructured":"Procino G, et al. Hereditary nephrogenic diabetes insipidus: molecular basis of the defect and potential novel strategies for treatment. J Genet Syndr Gene Ther. 2014;5:2.","journal-title":"J Genet Syndr Gene Ther"},{"key":"2652_CR13","doi-asserted-by":"publisher","first-page":"12949","DOI":"10.1073\/pnas.1104691108","volume":"108","author":"ET Olesen","year":"2011","unstructured":"Olesen ET, et al. Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus. Proc Natl Acad Sci USA. 2011;108:12949\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2652_CR14","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1172\/JCI9154","volume":"106","author":"J Yun","year":"2000","unstructured":"Yun J, et al. Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene. J Clin Invest. 2000;106:1361\u201371.","journal-title":"J Clin Invest"},{"key":"2652_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1152\/ajplegacy.1964.206.2.425","volume":"206","author":"H Valtin","year":"1964","unstructured":"Valtin H, Schroeder HA. Familial hypothalamic diabetes insipidus in rats (Brattleboro strain). Am J Physiol. 1964;206:425\u201330.","journal-title":"Am J Physiol"},{"key":"2652_CR16","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1172\/JCI39680","volume":"119","author":"JH Li","year":"2009","unstructured":"Li JH, et al. A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus. J Clin Invest. 2009;119:3115\u201326.","journal-title":"J Clin Invest"},{"key":"2652_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12896-018-0430-5","volume":"18","author":"T Kobayashi","year":"2018","unstructured":"Kobayashi T, et al. Successful production of genome-edited rats by the rGONAD method. BMC Biotechnol. 2018;18:19.","journal-title":"BMC Biotechnol"},{"key":"2652_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/dgd.12746","volume":"63","author":"M Namba","year":"2021","unstructured":"Namba M, et al. GONAD: a new method for germline genome-editing in mice and rats. Dev Growth Differ. 2021;63:439\u201347.","journal-title":"Dev Growth Differ"},{"key":"2652_CR19","doi-asserted-by":"publisher","first-page":"20836","DOI":"10.1038\/s41598-021-00354-y","volume":"11","author":"M Namba","year":"2021","unstructured":"Namba M, et al. Creation of X-linked Alport syndrome rat model with Col4a5 deficiency. Sci Rep. 2021;11:20836.","journal-title":"Sci Rep"},{"key":"2652_CR20","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1038\/s41440-023-01451-3","volume":"46","author":"H Ito","year":"2023","unstructured":"Ito H, et al. Pericyte detachment and renal congestion involve interstitial injury and fibrosis in Dahl salt-sensitive rats and humans with heart failure. Hypertens Res. 2023;46:2705\u201317.","journal-title":"Hypertens Res"},{"key":"2652_CR21","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1097\/HJH.0000000000003191","volume":"40","author":"T Matsuki","year":"2022","unstructured":"Matsuki T, et al. Inhibition of platelet-derived growth factor pathway suppresses tubulointerstitial injury in renal congestion. J Hypertens. 2022;40:1935\u201349.","journal-title":"J Hypertens"},{"key":"2652_CR22","doi-asserted-by":"publisher","first-page":"106524","DOI":"10.1016\/j.phrs.2022.106524","volume":"186","author":"G Anan","year":"2022","unstructured":"Anan G, et al. Inhibition of sodium-glucose cotransporter 2 suppresses renal stone formation. Pharmacol Res. 2022;186:106524.","journal-title":"Pharmacol Res"},{"key":"2652_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10157-018-1669-9","volume":"23","author":"A Wang","year":"2019","unstructured":"Wang A, et al. Hydrochlorothiazide ameliorates polyuria caused by tolvaptan treatment of polycystic kidney disease in PCK rats. Clin Exp Nephrol. 2019;23:455\u201364.","journal-title":"Clin Exp Nephrol"},{"key":"2652_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27\u201331.","journal-title":"J Basic Clin Pharm"},{"key":"2652_CR25","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/1440-1681.12666","volume":"43","author":"GS Baturina","year":"2016","unstructured":"Baturina GS, et al. Brattleboro rats have impaired apical membrane water permeability regulation in the outer medullary collecting duct principal cells. Clin Exp Pharmacol Physiol. 2016;43:1225\u201333.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"2652_CR26","first-page":"F159","volume":"240","author":"F Morel","year":"1981","unstructured":"Morel F. Sites of hormone action in the mammalian nephron. Am J Physiol. 1981;240(3):F159\u201364.","journal-title":"Am J Physiol"},{"issue":"12","key":"2652_CR27","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1681\/ASN.2017030295","volume":"28","author":"LC Veiras","year":"2017","unstructured":"Veiras LC, et al. Sexual dimorphic pattern of renal transporters and electrolyte homeostasis. J Am Soc Nephrol. 2017;28(12):3504\u201317.","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"2652_CR28","doi-asserted-by":"publisher","first-page":"991705","DOI":"10.3389\/fphys.2022.991705","volume":"29","author":"MM Stadt","year":"2022","unstructured":"Stadt MM, Layton AT. Sex and species differences in epithelial transport in rat and mouse kidneys: modeling and analysis. Front Physiol. 2022;29(13):991705.","journal-title":"Front Physiol"},{"key":"2652_CR29","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1681\/ASN.2008050513","volume":"19","author":"EM Zeisberg","year":"2008","unstructured":"Zeisberg EM, et al. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol. 2008;19:2282\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"2652_CR30","first-page":"645","volume":"94","author":"S Ishidoya","year":"2003","unstructured":"Ishidoya S, et al. Pathophysiology and clinical implication of obstructive nephropathy. Nihon Hinyokika Gakkai Zasshi. 2003;94:645\u201355.","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"2652_CR31","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00424-009-0667-x","volume":"458","author":"KS Parreira","year":"2009","unstructured":"Parreira KS, et al. Expression patterns of the aquaporin gene family during renal development: influence of genetic variability. Pflugers Arch. 2009;458:745\u201359.","journal-title":"Pflugers Arch"},{"key":"2652_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1124\/jpet.362.100351","volume":"389","author":"K Kylie","year":"2024","unstructured":"Kylie K, et al. G-protein coupled receptors expressed in human uterine tissues: novel targets for labour management. J Pharmacol Exp Ther. 2024;389:362.","journal-title":"J Pharmacol Exp Ther"},{"key":"2652_CR33","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/0030-4220(75)90441-7","volume":"40","author":"H Klein","year":"1975","unstructured":"Klein H. Dental fluorosis associated with hereditary diabetes insipidus. Oral Surg Oral Med Oral Pathol. 1975;40:736\u201341.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"2652_CR34","first-page":"89","volume":"1988","author":"M Mizohata","year":"1988","unstructured":"Mizohata M, et al. Effect of fluoride on the molar and its periodontal tissues in growing rats. J Jpn Stomatol Soc. 1988;1988:89\u201398.","journal-title":"J Jpn Stomatol Soc"},{"key":"2652_CR35","first-page":"128","volume":"16","author":"WK Seow","year":"1994","unstructured":"Seow WK, Thomsett MJ. Dental fluorosis as a complication of hereditary diabetes insipidus: studies of six affected patients. Pediatr Dent. 1994;16:128\u201332.","journal-title":"Pediatr Dent"},{"key":"2652_CR36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1651-2227.1994.tb13072.x","volume":"83","author":"B Jakobsson","year":"1994","unstructured":"Jakobsson B, Berg U. Effect of hydrochlorothiazide and indomethacin treatment on renal function in nephrogenic diabetes insipidus. Acta Paediatr. 1994;83:522\u20135.","journal-title":"Acta Paediatr"},{"key":"2652_CR37","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1093\/ndt\/gfh172","volume":"19","author":"S Sasaki","year":"2004","unstructured":"Sasaki S. Nephrogenic diabetes insipidus: update of genetic and clinical aspects. Nephrol Dial Transplant. 2004;19:1351\u20133.","journal-title":"Nephrol Dial Transplant"},{"key":"2652_CR38","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1007\/s00467-005-2057-8","volume":"20","author":"A Soylu","year":"2005","unstructured":"Soylu A, et al. Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus. Pediatr Nephrol. 2005;20:1814\u20137.","journal-title":"Pediatr Nephrol"},{"key":"2652_CR39","first-page":"1005","volume":"58","author":"CW Havard","year":"1965","unstructured":"Havard CW. Thiazide-induced antidiuresis in diabetes insipidus. Proc R Soc Med. 1965;58:1005\u20137.","journal-title":"Proc R Soc Med"},{"key":"2652_CR40","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1097\/01.ASN.0000143476.93376.04","volume":"15","author":"GH Kim","year":"2004","unstructured":"Kim GH, et al. Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel. J Am Soc Nephrol. 2004;15:2836\u201343.","journal-title":"J Am Soc Nephrol"},{"key":"2652_CR41","first-page":"F756","volume":"277","author":"KR C\u00e9sar","year":"1999","unstructured":"C\u00e9sar KR, Magaldi AJ. Thiazide induces water absorption in the inner medullary collecting duct of normal and Brattleboro rats. Am J Physiol. 1999;277:F756\u201360.","journal-title":"Am J Physiol"},{"key":"2652_CR42","first-page":"85","volume":"57","author":"M Fujimoto","year":"2014","unstructured":"Fujimoto M, et al. Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan. Yonago Acta Med. 2014;57:85\u201391.","journal-title":"Yonago Acta Med"},{"issue":"4","key":"2652_CR43","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1038\/srep05396","volume":"23","author":"M Inui","year":"2014","unstructured":"Inui M, et al. Rapid generation of mouse models with defined point mutations by the CRISPR\/Cas9 system. Sci Rep. 2014;23(4):5396.","journal-title":"Sci Rep"},{"issue":"10","key":"2652_CR44","doi-asserted-by":"publisher","first-page":"919155","DOI":"10.3389\/fcell.2022.919155","volume":"17","author":"Y Lin","year":"2022","unstructured":"Lin Y, et al. Application of CRISPR\/Cas9 system in establishing large animal models. Front Cell Dev Biol. 2022;17(10):919155.","journal-title":"Front Cell Dev Biol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02652-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02652-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02652-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T09:02:09Z","timestamp":1751014929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02652-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2652"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02652-5","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Division of Integrative Renal Replacement Therapy (T.H., S.S., C.T., and T.M.) was financially supported by JMS Co. Ltd., Terumo Corporation, and Southern TOHOKU Hospital Group (STHG). All the other authors declared no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures involving animals were performed in accordance with the ethical standards of the institution where the studies were conducted. This study was approved by the Tohoku Medical and\u00a0Pharmaceutical University Animal Experiment Committee (approval nos. A20015, A21011-cn, A22039-cn, A23033-cn, and\u00a0A24037-cn).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}